期刊
AAPS PHARMSCITECH
卷 19, 期 8, 页码 3388-3402出版社
SPRINGER
DOI: 10.1208/s12249-018-1097-x
关键词
pharmaceutical additive manufacturing; 3D printing; drug delivery system; personalized dosages; patient-centered drug development
资金
- National Institute of General Medical Sciences (NIGMS), a component of NIH [P20GM104932]
Inter-individual variability is always an issue when treating patients of different races, genders, ages, pharmacogenetics, and pharmacokinetic characteristics. However, the development of novel dosage forms is limited by the huge investments required for production line modifications and dosages diversity. Additive manufacturing (AM) or 3D printing can be a novel alternative solution for the development of controlled release dosages because it can produce personalized or unique dosage forms and more complex drug-release profiles. The primary objective of this manuscript is to review the 3D printing processes that have been used in the pharmaceutical area, including their general aspects, materials, and the operation of each AM technique. Advantages and shortcomings of the technologies are discussed with respect to practice and practical applications. Thus, this review will provide an overview and discussion on advanced pharmaceutical AM technologies, which can be used to produce unique controlled drug delivery systems and personalized dosages for the future of personalized medicine.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据